Catalyst Wire Dossier Catalyst Wire Dossier

VPD-737

· Vyne Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VPD-737, covering 2022-05-13 to 2022-05-13. Get the full timeline:

Most recent: Clinical Trial Update: VPD-737 for Treatment of Chronic Pruritus [Phase 2]

See pricing